Cargando…
Prevention and Management Strategies for Diabetic Neuropathy
Diabetic neuropathy (DN) is a common complication of diabetes that is becoming an increasing concern as the prevalence of diabetes rapidly rises. There are several types of DN, but the most prevalent and studied type is distal symmetrical polyneuropathy, which is the focus of this review and is simp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410148/ https://www.ncbi.nlm.nih.gov/pubmed/36013364 http://dx.doi.org/10.3390/life12081185 |
_version_ | 1784775024053321728 |
---|---|
author | Smith, Sasha Normahani, Pasha Lane, Tristan Hohenschurz-Schmidt, David Oliver, Nick Davies, Alun Huw |
author_facet | Smith, Sasha Normahani, Pasha Lane, Tristan Hohenschurz-Schmidt, David Oliver, Nick Davies, Alun Huw |
author_sort | Smith, Sasha |
collection | PubMed |
description | Diabetic neuropathy (DN) is a common complication of diabetes that is becoming an increasing concern as the prevalence of diabetes rapidly rises. There are several types of DN, but the most prevalent and studied type is distal symmetrical polyneuropathy, which is the focus of this review and is simply referred to as DN. It can lead to a wide range of sensorimotor and psychosocial symptoms and is a major risk factor for diabetic foot ulceration and Charcot neuropathic osteoarthropathy, which are associated with high rates of lower limb amputation and mortality. The prevention and management of DN are thus critical, and clinical guidelines recommend several strategies for these based on the best available evidence. This article aims to provide a narrative review of DN prevention and management strategies by discussing these guidelines and the evidence that supports them. First, the epidemiology and diverse clinical manifestations of DN are summarized. Then, prevention strategies such as glycemic control, lifestyle modifications and footcare are discussed, as well as the importance of early diagnosis. Finally, neuropathic pain management strategies and promising novel therapies under investigation such as neuromodulation devices and nutraceuticals are reviewed. |
format | Online Article Text |
id | pubmed-9410148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94101482022-08-26 Prevention and Management Strategies for Diabetic Neuropathy Smith, Sasha Normahani, Pasha Lane, Tristan Hohenschurz-Schmidt, David Oliver, Nick Davies, Alun Huw Life (Basel) Review Diabetic neuropathy (DN) is a common complication of diabetes that is becoming an increasing concern as the prevalence of diabetes rapidly rises. There are several types of DN, but the most prevalent and studied type is distal symmetrical polyneuropathy, which is the focus of this review and is simply referred to as DN. It can lead to a wide range of sensorimotor and psychosocial symptoms and is a major risk factor for diabetic foot ulceration and Charcot neuropathic osteoarthropathy, which are associated with high rates of lower limb amputation and mortality. The prevention and management of DN are thus critical, and clinical guidelines recommend several strategies for these based on the best available evidence. This article aims to provide a narrative review of DN prevention and management strategies by discussing these guidelines and the evidence that supports them. First, the epidemiology and diverse clinical manifestations of DN are summarized. Then, prevention strategies such as glycemic control, lifestyle modifications and footcare are discussed, as well as the importance of early diagnosis. Finally, neuropathic pain management strategies and promising novel therapies under investigation such as neuromodulation devices and nutraceuticals are reviewed. MDPI 2022-08-03 /pmc/articles/PMC9410148/ /pubmed/36013364 http://dx.doi.org/10.3390/life12081185 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Smith, Sasha Normahani, Pasha Lane, Tristan Hohenschurz-Schmidt, David Oliver, Nick Davies, Alun Huw Prevention and Management Strategies for Diabetic Neuropathy |
title | Prevention and Management Strategies for Diabetic Neuropathy |
title_full | Prevention and Management Strategies for Diabetic Neuropathy |
title_fullStr | Prevention and Management Strategies for Diabetic Neuropathy |
title_full_unstemmed | Prevention and Management Strategies for Diabetic Neuropathy |
title_short | Prevention and Management Strategies for Diabetic Neuropathy |
title_sort | prevention and management strategies for diabetic neuropathy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410148/ https://www.ncbi.nlm.nih.gov/pubmed/36013364 http://dx.doi.org/10.3390/life12081185 |
work_keys_str_mv | AT smithsasha preventionandmanagementstrategiesfordiabeticneuropathy AT normahanipasha preventionandmanagementstrategiesfordiabeticneuropathy AT lanetristan preventionandmanagementstrategiesfordiabeticneuropathy AT hohenschurzschmidtdavid preventionandmanagementstrategiesfordiabeticneuropathy AT olivernick preventionandmanagementstrategiesfordiabeticneuropathy AT daviesalunhuw preventionandmanagementstrategiesfordiabeticneuropathy |